BioStem Technologies, Inc. (BSEM)
4.879
-0.32
(-6.17%)
USD |
OTCM |
Apr 10, 15:24
BioStem Technologies Total Assets (Quarterly) : 50.20M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 16.32M |
| Iovance Biotherapeutics, Inc. | 913.17M |
| Protokinetix, Inc. | 0.4776M |
| GB Sciences, Inc. | 0.0945M |
| Travere Therapeutics, Inc. | 605.19M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.06M |
| Shareholders Equity (Quarterly) | 39.14M |
| Debt to Equity Ratio | 0.0851 |
| Current Ratio | 4.118 |
| Net Debt Paydown Yield | 0.36% |